Table 1. Association between LASP-1 expression and clinical characteristics in ccRCC patients.
Variables | No. | LASP-1 expression | P value | |
Low | High | |||
Total | 216 | 124 | 92 | |
Gender | 0.761 | |||
Female | 82 | 46 | 36 | |
Male | 134 | 78 | 56 | |
Age, years | 0.606 | |||
≤63 | 113 | 63 | 50 | |
>63 | 103 | 61 | 42 | |
Tumor size (cm) | 0.002 | |||
≤6 | 110 | 58 | 52 | |
>6 | 106 | 34 | 72 | |
Fuhrman nuclear grade | 0.081 | |||
1/2 | 97 | 62 | 35 | |
3/4 | 119 | 62 | 57 | |
TNM stage | 0.005 | |||
1/2 | 172 | 107 | 65 | |
3/4 | 44 | 17 | 27 | |
Recurrence | 0.006 | |||
No | 89 | 61 | 28 | |
Yes | 127 | 63 | 64 | |
Death | 0.026 | |||
No | 149 | 93 | 56 | |
Yes | 67 | 31 | 36 |
Abbreviations: ccRCC, clear cell renal cell cancer; LASP-1, LIM and SH3 protein 1.